Graham Dunn mostly deals with Psychiatry, Randomized controlled trial, Schizophrenia, Psychosis and Clinical psychology. All of his Psychiatry and Cognitive therapy, Mental health, Antipsychotic, Depression and Positive and Negative Syndrome Scale investigations are sub-components of the entire Psychiatry study. His study in Randomized controlled trial is interdisciplinary in nature, drawing from both Psychological intervention, Patient satisfaction, Clinical trial, Schizoaffective disorder and Physical therapy.
Graham Dunn interconnects Cognitive behavioral therapy and Anxiety in the investigation of issues within Schizophrenia. His studies in Psychosis integrate themes in fields like Distress and Cognition. His work in the fields of Clinical psychology, such as Psychometrics, intersects with other areas such as Injury prevention.
Graham Dunn mainly focuses on Psychiatry, Randomized controlled trial, Clinical psychology, Psychosis and Mental health. His work in the fields of Psychiatry, such as Schizophrenia, Psychological intervention, Depression and Anxiety, overlaps with other areas such as Suicide prevention. His work carried out in the field of Randomized controlled trial brings together such families of science as Psychotherapist, Physical therapy, Clinical trial and Intervention.
Graham Dunn combines subjects such as Cognitive behavioral therapy and Paranoia with his study of Clinical psychology. His Psychosis study often links to related topics such as Cognition. His work deals with themes such as Nursing, Public health, Older people and Family medicine, which intersect with Mental health.
His scientific interests lie mostly in Psychiatry, Clinical psychology, Mental health, Randomized controlled trial and Nursing. His work on Psychosis, Worry and Paranoid Disorders as part of his general Psychiatry study is frequently connected to Suicide prevention and Suicidal ideation, thereby bridging the divide between different branches of science. His Psychosis study combines topics in areas such as Schizophrenia and Cognitive therapy.
His Schizophrenia research is multidisciplinary, incorporating elements of Internal medicine and Cognition. His Clinical psychology study deals with Paranoia intersecting with Anxiety and Social psychology. His work in Randomized controlled trial tackles topics such as Physical therapy which are related to areas like Average treatment effect.
Psychiatry, Clinical psychology, Randomized controlled trial, Psychosis and Cognitive therapy are his primary areas of study. His work often combines Psychiatry and Suicide prevention studies. His Clinical psychology research is multidisciplinary, incorporating perspectives in Intervention and Depression.
His Randomized controlled trial study integrates concerns from other disciplines, such as Mental health and Persecutory delusion. The study incorporates disciplines such as Developmental psychology, Placebo, Psychological trauma and Cannabis in addition to Psychosis. His Schizophrenia study integrates concerns from other disciplines, such as Clinical trial and Cognition.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Applied Multivariate Data Analysis.
D. S. Coad;B. S. Everitt;G. Dunn.
The Statistician (1993)
Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function?
Kennedy Cruickshank;Lisa Riste;Simon G. Anderson;John S. Wright.
Circulation (2002)
Measuring psychiatric disorder in the community: a standardized assessment for use by lay interviewers.
Glyn Lewis;Anthony J. Pelosi;Ricardo Araya;Graham Dunn.
Psychological Medicine (1992)
Randomized Controlled Trial of the Effect on Quality of Life of Second- vs First-Generation Antipsychotic Drugs in Schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1)
Peter B. Jones;Thomas R. E. Barnes;Linda Davies;Graham Dunn.
Archives of General Psychiatry (2006)
The Camberwell Assessment of Need: the validity and reliability of an instrument to assess the needs of people with severe mental illness.
Michael Phelan;Mike Slade;Graham Thornicroft;Graham Dunn.
British Journal of Psychiatry (1995)
Depressive disorders in Europe: prevalence figures from the ODIN study.
Jose Luis Ayuso-Mateos;Jose Luis Vázquez-Barquero;Christopher Dowrick;Ville Lehtinen.
British Journal of Psychiatry (2001)
A Brief Mental Health Outcome Scale-Reliability and Validity of the Global Assessment of Functioning (GAF)
Steven H. Jones;Graham Thornicroft;Michael Coffey;Graham Dunn.
British Journal of Psychiatry (1995)
Psychological investigation of the structure of paranoia in a non-clinical population.
Daniel Freeman;Philippa A. Garety;Paul E. Bebbington;Benjamin Smith.
British Journal of Psychiatry (2005)
The Lambeth Early Onset (LEO) Team: randomised controlled trial of the effectiveness of specialised care for early psychosis
Tom K J Craig;Philippa Garety;Paddy Power;Nikola Rahaman.
BMJ (2004)
Negative life events, social support and gender difference in depression: a multinational community survey with data from the ODIN study.
Odd Steffen Dalgard;Christopher Dowrick;Ville Lehtinen;Jose Luis Vazquez-Barquero.
Social Psychiatry and Psychiatric Epidemiology (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Oxford
King's College London
University of Sussex
King's College London
University College London
London School of Economics and Political Science
University of Manchester
University of Nottingham
King's College London
University of Manchester
University of New South Wales
University of Georgia
University of Maryland, College Park
Carlsberg Laboratory
Dongguk University
Technical University of Munich
University of Alaska Fairbanks
University of Trás-os-Montes and Alto Douro
Science for Life Laboratory
King's College London
Tohoku University
Max Planck Society
University of Manchester
University of Edinburgh
Boston University
University of Florida